Skip to main content

Table 2 Clinical presentations of patients acquiring CVA6 and non-CVA6 enterovirus infection

From: Atypical hand-foot-mouth disease in children: a hospital-based prospective cohort study

 

CVA6 positive (N=81)

Non-CVA6* (N=20)

P value

Demographics

Age (year)

3.5 (±3.2)

2.8 (±1.5)

0.92

Male

54 (67%)

11 (55%)

0.33

Female

27 (33%)

9 (45%)

Sites

Limbs

80 (99%)

18 (90%)

0.10

  Arm/Leg/Thigh

56 (69%)

16 (80%)

0.79

Trunk

22 (27%)

7 (35%)

0.58

Buttocks

25 (30%)

6 (30%)

1.00

Face

34 (41%)

8 (40%)

0.80

  Ear lobes

11 (13%)

0

0.12

  Perioral area

23 (28%)

4 (20%)

0.27

Morphology

Large vesicles

45 (56%)

5 (25%)

0.02

Symptoms

Fever

66 (80%)

15 (75%)

0.37

Sore throat

49 (60%)

10 (50%)

0.45

Cough/rhinorrhea

23 (28%)

7 (35%)

0.58

Vomit/diarrhea

11 (13%)

6 (30%)

0.10

Skin lesions

   

  Itchiness

27 (33%)

5 (25%)

0.60

  Pigmentation

6 (7%)

3 (15%)

0.34

  Prickle

2 (2%)

0 (0%)

1.00

Myoclonic jerks

11 (13%)

3 (15%)

1.00

Hospitalization

Days (days)

3.4 (± 1.3)

2.3 (± 0.6)

0.24

Age (years)

2.3 (± 3.1)

2.3 (± 0.6)

0.30

  1. CVA6 denotes coxsackievirus A6.
  2. * including 6 of CVA16, 1 of EV71, 1 of CVA5 and 12 of non-typable enterovirus.